Early screening is the key to managing breast cancer - thesuburban.com
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
According to the Quebec Cancer Foundation, there were an estimated 9,505 cases of breast cancer in 2025 in the province. Breast cancer is very curable in Quebec, especially when caught early. Overall, about 85 to 89 per cent of people diagnosed with are long-term survivors, and early detection means that 70 to 82 per cent of breast cancers that are diagnosed at an early stage have the highest cure rates. The keyword here is “early,” something that is possible, given the existing research, but yet to be integrated into the Quebec healthcare system. A new screening process called the PERSPECTIVE project (PErsonalized Risk Stratification for Prevention and Early deteCTIon of breast cancer), which was partially funded by the Quebec Breast Cancer Foundation (QBCF), uses a saliva test combined with a lifestyle and family history questionnaire to assess a woman’s personalized risk of developing breast cancer. Currently, Quebec uses age alone to determine when a person should get a mammogram, starting at 50. Nine provinces in Canada recommend and cover regular screening mammograms for people starting at age 40.
This article is an excerpt. To read the full content, visit the original source. thesuburban.com
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!